Indication

Haemophilus osteomyelitis

Haemophilus osteomyelitis is an invasive bone infection caused by bacteria of the genus *Haemophilus*, most classically encapsulated *Haemophilus influenzae* type b or, less commonly, non-typeable strains and other species such as *Haemophilus parainfluenzae*. Read more about Haemophilus osteomyelitis

32 drugs 28 manufacturers

Advertisement

Drugs that treat it

Common Haemophilus osteomyelitis therapies.

Showing 1–9 of 32 drugs

Filter & compare in the drug finder →Opens the drug finder with Haemophilus osteomyelitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Haemophilus osteomyelitis.

Haemophilus osteomyelitis is an invasive bone infection caused by bacteria of the genus *Haemophilus*, most classically encapsulated *Haemophilus influenzae* type b or, less commonly, non-typeable strains and other species such as *Haemophilus parainfluenzae*.

Pathophysiologically, the condition typically arises from hematogenous dissemination following respiratory tract colonization or bacteremia, seeding the metaphysis of long bones or, occasionally, the axial skeleton.

Historically seen as acute hematogenous osteomyelitis in unimmunized infants and young children, it can also manifest as vertebral osteomyelitis or contiguous skeletal infection in immunocompromised adults or patients with anatomical defects.

Clinical presentation is characterized by fever, localized skeletal pain, swelling, erythema, and impaired mobility or refusal to bear weight.

Personalize your experience

Follow Haemophilus osteomyelitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it